University of Minnesota researchers revealed how the novel coronavirus binds to human cells
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
Johnson & Johnson announced a lead vaccine candidate for COVID-19
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
Study documents widespread contamination of environment near patients with COVID-19
On Mar. 29, 2020, a study by UNMC/Nebraska Medicine/NSRI researchers provides new evidence of SARS-CoV-2 environmental contamination in…
Military scientists, engineers develop ventilator prototype
On Mar. 27, 2020, scientists and engineers at Naval Surface Warfare Center Panama City Division announced development of…
Abbott launched molecular point-of-care test to detect novel Coronavirus in as Little as five minutes
On Mar. 27, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the fastest available…
Oxford University COVID-19 vaccine programme opened for clinical trial recruitment
On Mar. 27, 2020, University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19…
Abbott launched molecular point-of-care test to detect novel Coronavirus in as little as five minutes
On Mar. 27, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the fastest…
COVID-19 will likely lead to US drug shortages
On Mar. 27, 2020, researchers at the University of Minnesota reported that the COVID-19 pandemic stands a good…
Humanigen submitted phase III protocol synopsis to FDA for lenzilumab for Coronavirus treatment
On Mar. 27, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to U.S. Food…
Rice University and Metric Technologies develop $300 ventilator freely available
On Mar. 27, 2020, Rice University and Canadian global health design firm Metric Technologies announced they have developed…
Novartis and life sciences companies commited to fight against COVID-19 with Bill & Melinda Gates Foundation
On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced a collaboration to accelerate the…
COVID-19 first target of new AI research consortium
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
FDA supports transparency and collaboration in drug approval process as clinical data summary pilot concluded
On Mar. 26, 2020, the FDA reported that it had become increasingly clear that the FDA needed to…
U.S. hospitals could be overwhelmed in the second week of April and US deaths could total 81,000 by July
On Mar. 26, 2020, in a forecast based on recent data analyses, Institute for Health Metrics (IHME) researchers…
Cerus formed group to research optimal production of COVID-19 convalescent plasma
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
Dynavax and CEPI announced collaboration to support effort to develop vaccine for COVID-19
On Mar. 26, 2020, Dynavax and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a collaboration supporting the…
Sartorius Stedim Biotech delivered indispensable biopharma supplies
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and sell the assay in Europe
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
Vir Biotech proceeded with two clinical development candidates for COVID-19
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
CHF Solutions announced COVID-19 patients treated with Aquadex therapy for fluid management with Coronavirus treatment
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
Mylan waives US marketing exclusivity for Lopinavir/Ritonavir to ensure availability for COVID-19 patient needs
On Mar. 25, 2020, Mylan announced that it had waived its exclusive rights in the U.S. to distribute…
T2 Biosystems announced worldwide licensing agreement of COVID-19, novel Coronavirus assay
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
Resverlogix clinical candidate apabetalone featured as potential COVID-19 treatment in publication
On Mar. 24, 2020, Resverlogix announced a Mar. 23, 2020 bioRxiv publication that has shown apabetalone to inhibit…
Bausch Health donated products and supplies in response to COVID-19 pandemic
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, a new international project aims to enroll 500 COVID-19 patients to search for genetic…
Oxford University’s COVID-19 research received government funding
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
Dynavax and Clover Biopharmaceuticals announced COVID-19 research collaboration
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point ofcCare molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…